ArticleBMC pregnancy and childbirth2026
Pregnancy outcomes and risk factors analysis in patients with chronic kidney disease: a nested case-control study.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundChronic kidney disease (CKD) poses significant risks during pregnancy. Accurate early risk prediction remains challenging due to physiological changes, disease heterogeneity, and limitations of various independent renal markers in pregnancy. The aim of this study is to explore the clinical and laboratory variables in early pregnancy that can predict adverse neonatal and maternal outcomes, thereby facilitating the grading management of CKD.
methodsA nested case-control study was conducted at Zhongnan Hospital, Wuhan University (2018-2024). We enrolled 187 pregnant women diagnosed with CKD before 12 weeks gestation and 187 controls who were matched in terms of age and major comorbidities but without CKD. CKD staging was based on the first trimester estimated glomerular filtration rate (eGFR) using the CKD-EPI equation and urine albumin-to-creatinine ratio (uACR). Adverse maternal outcomes(AMOs) and adverse neonatal outcomes (ANOs) were compared. Multivariable logistic regression identified predictors.
resultsKey findings showed significantly higher rates of ANOs in CKD patients (61.5% vs. 16.04%, P < 0.01), including preterm birth (48.66% vs. 6.95%, P = 0.023), and SGA (13.90% vs. 2.67%, P < 0.001). AMOs occurred in 48.1% of CKD patients (vs. 4.81% controls, P < 0.001), predominantly preeclampsia (43.85%). Multivariable analysis identified independent risk factors for ANOs: new-onset CKD (OR = 4.447, 95%CI1.949-10.147, P < 0.001), severe proteinuria (OR = 2.487,95%CI 1.112-5.565,P = 0.027), and chronic hypertension (OR = 8.127, 95%CI 2.491-26.512,P = 0.001). These three factors can also affect the outcome of AMO. In addition, the maternal age(OR = 0.886, 95%CI 0.805-0.975, P = 0.013) and a creatinine level (≥ 90µmol/L)(OR = 5.898, 95%CI 1.468-23.702, P = 0.012)are also influencing factors for AMO.
conclusionCKD pregnancies pose significantly elevated risks for maternal and neonatal complications. Our findings identify specific early-pregnancy markers - namely serum creatinine (Scr) levels and severe proteinuria (uACR > 300 mg/g) - as critical thresholds for risk stratification, highlighting the necessity for intensified monitoring in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.